Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Treasury Shares (2016 - 2025)

Viking Therapeutics (VKTX) has disclosed Treasury Shares for 2 consecutive years, with $6.8 million as the latest value for Q4 2023.

  • Quarterly Treasury Shares changed 0.0% to $6.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2023, changed 0.0% year-over-year, with the annual reading at $6.8 million for FY2023, 0.0% changed from the prior year.
  • Treasury Shares hit $6.8 million in Q4 2023 for Viking Therapeutics, roughly flat from $6.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2024 to a low of $183095.0 in Q1 2021.
  • Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $2.1 million in 2025.
  • Biggest YoY gain for Treasury Shares was 32.69% in 2023; the steepest drop was 0.0% in 2023.
  • Year by year, Treasury Shares stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
  • Business Quant data shows Treasury Shares for VKTX at $6.8 million in Q4 2023, $6.8 million in Q3 2023, and $6.8 million in Q2 2023.